Lv3
346 积分 2024-07-28 加入
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
11天前
已完结
Efficient generation of epitope-targeted antibodies with Germinal
14天前
已完结
Discovery of a fully human antibody to the proximal membrane terminus of MUC1 based on a B-cell high-throughput screening technique
6个月前
已完结
Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model
6个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
6个月前
已完结
Navigating the complexities of drug development for inflammatory bowel disease
7个月前
已完结
Inflammatory Bowel Disease
7个月前
已完结
Sulfadiazine and phosphinothricin selection systems optimised for the transformation of tobacco BY-2 cells
7个月前
已完结
Innovative antibody therapeutic development in China compared with the USA and Europe
8个月前
已完结
Gout therapeutics and drug delivery
9个月前
已完结
皖公网安备34019202002308
